PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 134 filers reported holding PTC THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $16,478,000 | -69.2% | 324,750 | -72.9% | 0.33% | -82.0% |
Q1 2020 | $53,532,000 | +131.4% | 1,200,000 | +75.4% | 1.81% | +87.3% |
Q3 2019 | $23,133,000 | -24.8% | 684,000 | 0.0% | 0.96% | -9.3% |
Q2 2019 | $30,780,000 | +136.0% | 684,000 | +80.0% | 1.06% | +36.4% |
Q4 2018 | $13,042,000 | -59.4% | 380,000 | -44.4% | 0.78% | -47.2% |
Q3 2018 | $32,148,000 | -58.5% | 684,000 | -70.2% | 1.48% | -50.5% |
Q2 2018 | $77,406,000 | +3418.5% | 2,294,877 | +1812.4% | 2.98% | +971.9% |
Q2 2017 | $2,200,000 | – | 120,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |